Search Results 4971-4980 of 38944 for oral
Oral-maxillo facial surgery and traumatology. Department members collaborate with other specialists in audiology, speech and swallowing therapy ...
Oral Cavity & Pharynx. Uncategorized. 0.3. 0.0. 1.5. Target. 74.4%. 0.0. Data Sources: Incidence and Mortality from State Cancer Profiles (for FL, AZ, WI, IA.
Oral Cavity & Pharynx. Ovary. Pancreas. Stomach. Uncategorized. 0.0. 0.0. 0.0. Adults aged 50-75 years who reported. State. 67.1%. 0.0. 0.0. 0.0. 0.0 being up- ...
Oral Cavity & Pharynx. Uncategorized. 3.0. 1.9 being up-to-date with colorectal cancer screening. 0.8. 1.9. Target. 76.6%. 74.4%. 0.0. 0.0. Data Sources: ...
Oral Cavity & Pharynx. 9.5. County. 64.1%. Brain & ONS. 0.0. 0.0. Colorectal. Cervix. 0.0. 0.0. Adults aged 50-75 years who reported. State. 74.3%. Esophagus.
Oral Cavity & Pharynx. 1.4. 1.1. Target. 76.6%. 74.4%. Uncategorized. 0.0. 0.0. Data Sources: Incidence and Mortality from State Cancer Profiles (for FL, AZ, WI ...
The purpose of this study is to compare the effectiveness and safety of EG-1962 to the standard of care oral nimodipine for the treatment of adult patients who ...
Learn about innovative treatment for throat cancers, mouth cancers, tongue cancers, tonsil cancers and other cancers that affect the head and neck.
Other oral antibiotics within 28 days of randomization (with the exception of topical antibiotics or a 1-day course with an antibiotic). However, a patient ...
The purpose of this study is to evaluate the safety of oral daily dosing of tafamidis meglumine for patients who have either transthyretin genetic ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!